Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

VESTEX Apparel

K-Number: K180217 · 2018-05-18

ApplicantVestagen Protective Technologies, Inc.
Decision Date2018-05-18
Product CodeQBW
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

VESTEX Apparel is the device name listed in this FDA 510(k) record. The listed applicant is Vestagen Protective Technologies, Inc.. It received FDA 510(k) clearance on 2018-05-18 under 510(k) number K180217. The device is classified under product code QBW. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the VESTEX Apparel?

VESTEX Apparel is a medical device that received FDA 510(k) clearance on 2018-05-18. The listed applicant is Vestagen Protective Technologies, Inc.. The 510(k) number is K180217.

When did VESTEX Apparel receive FDA 510(k) clearance?

VESTEX Apparel received FDA 510(k) clearance on 2018-05-18, under 510(k) number K180217.

Who is the listed applicant for VESTEX Apparel?

The FDA 510(k) record lists Vestagen Protective Technologies, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for VESTEX Apparel?

The FDA product code for VESTEX Apparel is QBW.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT04745156A Study Using Brain Stimulation and Behavioral Therapy to Increase Extent of Resection in Low-Grade GliomasNOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑